JTE-907
JTE-907 is a highly selective, orally active CB2 receptor inverse agonist and exerts anti-inflammatory effects in vivo[1].
Product Specifications
CAS Number
[282089-49-0]
UNSPSC
12352005
Hazard Statement
H302
Target
Cannabinoid Receptor
Type
Reference compound
Related Pathways
GPCR/G Protein; Neuronal Signaling
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/jte-907.html
Purity
98.72
Solubility
DMSO : 125 mg/mL (ultrasonic)
Smiles
O=C(C1=CC2=C(NC1=O)C(OCCCCC)=C(OC)C=C2)NCC3=CC=C(OCO4)C4=C3
Molecular Formula
C24H26N2O6
Molecular Weight
438.47
Precautions
H302
References & Citations
[1]Ueda Y, et al. Involvement of cannabinoid CB (2) receptor-mediated response and efficacy of cannabinoid CB (2) receptor inverse agonist, JTE-907, in cutaneous inflammation in mice. Eur J Pharmacol. 2005 Sep 27;520 (1-3) :164-71.
Shipping Conditions
Room Temperature
Storage Conditions
4°C (Powder, stored under nitrogen)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
042787-ML650 100 µL
TGIF2, CT (TGIF2, Homeobox protein TGIF2, 5'-TG-3'-interacting factor 2, TGF-beta-induced transcription factor 2) (MaxLight 650) discontinued
Ask
View Details 
MBS6320251-01 0.1 mL
MEP1A, NT (MEP1A, Meprin A subunit alpha, Endopeptidase-2, N-benzoyl-L-tyrosyl-P-amino-benzoic acid hydrolase subunit alpha, PABA peptide hydrolase, PPH alpha) (MaxLight 650)
Ask
View Details